Developer docs
API playgroundTry for free, no card

Search company profiles

Gyros Protein Technologies

Full company profile

uuid000tgfa

Namestring
Gyros Protein Technologies
Legal namestring
Gyros Protein Technologies AB
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Gyros Protein Technologies AB is a specialty life sciences instrument company headquartered in Uppsala, Sweden, with operations in the United States, that designs and manufactures automated nanoliter-scale immunoassay systems (Gyrolab xPlore and xPand) and a portfolio of automated peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, and Sonata/Sonata XT) under the Gyrolab and PurePep brands. The company's core technology is a proprietary microfluidic disc platform in which samples and reagents are delivered to 15-nanoliter streptavidin-bead columns by centrifugal force and capillary action, enabling immunoassay runs that complete in approximately one hour with up to 960 data points per day and dramatic reductions in sample and reagent consumption relative to plate-based ELISA. Column profile technology provides a distinctive data quality layer beyond conventional plate readers.

The company sells to large biopharmaceutical companies, contract research organizations (CROs), vaccine developers, and cell and gene therapy developers, addressing applications including pharmacokinetics, biomarker analysis, immunogenicity testing, impurity analysis, titer analysis, and therapeutic peptide synthesis. Revenue is generated through a capital equipment + recurring consumables + services model: one-time sales of Gyrolab systems and peptide synthesizers, ongoing pull-through from proprietary microfluidic discs, reagents and ready-to-use kits, and paid custom assay development plus IQ/OQ qualification services. Distribution combines direct enterprise field sales with a Certified CRO Partner Program that currently includes Charles River Laboratories, Bioagilytix, Resolian, QPS, Nuvisan, Agilex Biolabs, Frontage, Icon Laboratory Services, and Quality Assistance, alongside a Gyrolab User Zone customer portal providing training, protocols, and a method database. The company was founded in 1993 as Gyros AB, acquired Protein Technologies in 2016, and has operated as a division of Mesa Laboratories, Inc. (NASDAQ: MLAB) since 2019.

Short descriptiontext

Gyros Protein Technologies designs and manufactures automated nanoliter-scale immunoassay systems (Gyrolab) and peptide synthesizers (PurePep) for biopharmaceutical companies, CROs, and vaccine and cell/gene therapy developers, generating revenue through capital equipment, recurring consumables, and custom services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMonmouth Junction, United States
HQ citystring
Monmouth Junction
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immunoassay instruments, peptide synthesis systems, bioanalytical testing, microfluidic lab technology, pharmacokinetic assays
Industry4 codes
1Cell-Based & Potency Assays (Bioassays)
CodeHLAGADAHPrimaryYes
2Small-Molecule Analytical Development & Method Validation (CMC)
CodeHLAGAHAFPrimaryNo
3Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
CodeHLAAAJAIPrimaryNo
4Quality Assurance, GxP Compliance & Auditing FSP
CodeHLAGAOAEPrimaryNo
NAICS code4 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Bioanalytical Immunoassay & Peptide Synthesis Instruments
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Instrument/System Sales
TypeOne Time License
Description

Sale of Gyrolab immunoassay systems (xPlore, xPand) and peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, Sonata/Sonata XT). Capital equipment sales model with high transaction values.

gyrosproteintechnologies.com
2Consumables and Reagents
TypeUsage Based
Description

Recurring revenue from microfluidic discs, reagents, ready-to-use kits, and peptide synthesis consumables. Gyrolab microfluidic discs, reagents and ready-to-use kits deliver performance at nanoliter scale, reducing sample and reagent volumes.

gyrosproteintechnologies.com
3Custom Assay Services
TypeProfessional Services
Description

Tailored assay development services supporting faster progress by helping optimize assay conditions, label biomolecules and prepare ready-to-use kit solutions. Includes IQ/OQ services and PEC services for peptide synthesis.

gyrosproteintechnologies.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Technology or R&D, Supply Chain
Pricing details1 tier
1Enterprise instrument systems with custom pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Gyrolab xPlore and xPand immunoassay systems, and peptide synthesizers are priced through direct quote requests. No public pricing available.

gyrosproteintechnologies.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Gyrolab
Description

Automated nanoliter-scale immunoassay platform for bioanalytical testing, pharmacokinetics, biomarkers, immunogenicity, and cell & gene therapy applications.

gyrosproteintechnologies.com
+1 more record
Core offering1 text field

Gyros Protein Technologies manufactures and sells the Gyrolab automated nanoliter-scale immunoassay systems (xPlore and xPand) along with proprietary microfluidic discs, kits, reagents, and software for bioanalytical testing in drug development. Under its PurePep brand it sells peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, Sonata/Sonata XT) and purification kits. The company also offers custom assay development, IQ/OQ qualification services, and a Certified CRO Partner Program serving biopharma, CRO, vaccine, and cell/gene therapy customers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Process up to 960 data points per day with minimal supervision
+4 more records
Product overview1 text field

Gyros Protein Technologies offers two integrated product lines under the Gyrolab and PurePep brands: the Gyrolab automated nanoliter-scale immunoassay platform comprising Gyrolab xPlore and Gyrolab xPand systems with associated software, consumables, and kits for bioanalytical testing; and PurePep peptide synthesizers including Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, and Sonata/Sonata XT for solid-phase peptide synthesis. The company also provides related reagents, purification solutions like PurePep EasyClean, and services including custom assay development, IQ/OQ qualification, and a certified CRO partner network. The portfolio supports biotherapeutic drug development from discovery through manufacturing across applications including pharmacokinetics, biomarkers, immunogenicity, impurity analysis, and peptide therapeutics.

Product and service14 records
1Gyrolab xPlore
CategoryImmunoassay Instrument
Description

Automated nanoliter-scale immunoassay system that uses microfluidic disc technology to deliver high-throughput pharmacokinetic, biomarker, and immunogenicity bioanalytical results for biopharmaceutical and CRO customers.

2Gyrolab xPand
CategoryImmunoassay Instrument
Description

Automated nanoliter-scale immunoassay instrument offering parallel processing for scalable bioanalytical workflows across drug development stages.

3Gyrolab Microfluidic Discs
CategoryImmunoassay Consumable
Description

Proprietary single-use discs containing nanoliter-scale streptavidin bead columns that enable automated immunoassay processing on Gyrolab xPlore and xPand systems.

4Gyrolab 2G Generic PK Kit
CategoryImmunoassay Kit
Description

Ready-to-use kit for pharmacokinetic studies that provides improved assay flexibility, sensitivity, and sample efficiency for therapeutic antibody development on Gyrolab systems.

5Gyrolab p24 Kit
CategoryImmunoassay Kit
Description

Assay kit designed for cell and gene therapy applications, enabling detection of lentiviral vector p24 components for immunogenicity monitoring.

6Gyrolab Human Cytokine Kit Reagents
CategoryImmunoassay Reagent
Description

Single-analyte cytokine assay reagents enabling automated detection of human cytokines (IL-4, IL-6, IL-10, IFN-gamma, TNF-alpha) on the Gyrolab platform.

7Symphony/Quartet Peptide Synthesizer
CategoryPeptide Synthesizer
Description

Legacy peptide synthesizer platform for solid-phase peptide synthesis supporting discovery and development peptide research.

8Prelude X Peptide Synthesizer
CategoryPeptide Synthesizer
Description

Advanced peptide synthesizer for automated solid-phase peptide synthesis with enhanced capabilities for complex sequences.

9Sonata/Sonata XT Peptide Synthesizer
CategoryPeptide Synthesizer
Description

Peptide synthesizer platform designed for scalable solid-phase peptide synthesis from research through manufacturing applications.

10PS3 Peptide Synthesizer
CategoryPeptide Synthesizer
Description

Legacy automated peptide synthesizer supporting standard and complex solid-phase peptide synthesis workflows.

11Tribute UV-IR Peptide Synthesizer
CategoryPeptide Synthesizer
Description

Peptide synthesizer featuring UV-IR monitoring for real-time synthesis tracking and optimization.

12PurePep EasyClean Purification Kits
CategoryPeptide Purification Kit
Description

Precipitation-free peptide purification kits that address HPLC delays, precipitation issues, and high costs in peptide purification workflows, saving 3-4 days per cycle.

13Custom Assay Development Services
CategoryCustom Assay Service
Description

Expert scientific services for assay optimization, custom biomolecule labeling, and preparation of ready-to-use kit solutions for Gyrolab-based workflows.

14IQ/OQ Services for Peptide Synthesizers
CategoryQualification Service
Description

Installation and operational qualification services for peptide synthesizers ensuring compliance with regulatory requirements.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Since 2019, Gyros Protein Technologies is a division of Mesa Labs, a growing confederation of leading-edge brands dedicated to 'Protecting the Vulnerable'. Mesa Labs includes Gyros AB, Protein Technologies Inc., Gyros Protein Technologies AB, Agena Bioscience, GKE-GmbH, and other subsidiaries.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner using the Gyrolab platform to support preclinical and clinical studies with consistent, high-quality immunoassay data. Automated workflows reduce resource use and increase throughput while providing stability needed for regulated environments.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner utilizing Gyrolab platform for biomarker and immunogenicity assays. Bioagilytix has utilized custom services including Custom Biomolecule Labelling Services for project-specific host-cell-protein assays.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner using Gyrolab systems for biomarker, pharmacokinetic and immunogenicity assay development, validation and execution for drug development.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner leveraging Gyrolab platform capabilities for bioanalytical studies requiring high throughput and low sample volume.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner using Gyrolab platform for agile bioanalytical support and client projects.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner choosing Gyrolab for high throughput requirements and low reagent volume concerns, including discovery/preclinical mouse models and rare matrices.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner utilizing Gyrolab for automated immunoassay workflows, high throughput sample analysis, and precious sample volume conservation.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner using Gyrolab platform for robust studies requiring high throughput, low sample volume, or challenging analytes and matrices.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Certified CRO Partner utilizing Gyrolab for analytical methods including titer and residual process impurity analysis.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Symphogen A/S used Gyrolab system to develop 2-plex immunoassays for Sym015, a novel anti-cancer biotherapeutic comprising two monoclonal antibodies. Gyrolab methods are used for CMC, manufacturing control, and clinical bioanalysis.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Alexion used Gyrolab system for quantitation of free complement protein C5a in human plasma, developing assays to address C5 interference challenges. Gyrolab became their default technology of choice for free target quantification.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Oxford Biomedica, pioneer in lentiviral vector gene therapy (Kymriah), adopted Gyrolab xPlore to measure lentiviral vector immunogenicity 24x faster with 10x less sample volume than ELISA.

Strategic tierNotableTypeTechnology or Integration
Description

Sanofi Deutschland GmbH uses Gyrolab methods to support clinical and nonclinical studies, improving analyst efficiency in the lab and keeping teams at the cutting edge of drug development.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor offering automated electrochemiluminescence immunoassay platforms (Meso QuickPlex, SECTOR) used in drug development, biomarkers and immunogenicity — same buyer set (biopharma, CROs) and similar workflow (PK, immunogenicity, biomarkers) as Gyrolab.

TypeBroad incumbent
Description

Larger life-science tools provider with automated immunoassay / protein analysis platforms (e.g., Simple Western/Jess) serving overlapping biopharma and academic customers; broader portfolio but competes directly for immunoassay workflow share.

TypeDirect peer
Description

Multiplexed bead-based immunoassay platform (xMAP) used for biomarker, PK and immunogenicity assays across biopharma and CROs — directly overlapping with Gyrolab's biomarker and immunogenicity use cases.

TypeDirect peer
Description

Single-molecule array (Simoa) ultra-sensitive immunoassay platform targeting neurology, immunology and oncology biomarkers — comparable technology category (automated, low-volume immunoassays) and similar biopharma/biomarker buyer.

TypeDirect peer
Description

Peptide synthesizer vendor with the Liberty and Discover Bio series for SPPS — directly competes with PurePep Symphony, Prelude X and Sonata lines for therapeutic peptide development customers.

TypeDirect peer
Description

Provides peptide synthesisers (Syro I/II) and purification/consumable solutions that overlap with PurePep EasyClean and SPPS workflows in pharmaceutical and academic peptide labs.

TypeBroad incumbent
Description

Large bioprocess and lab products supplier whose bioanalytics portfolio (inc. cell line and process analytics) is sold into the same biopharma buyer set; competes indirectly for spend allocated to upstream/downstream characterization tools.

TypeBroad incumbent
Description

Diversified life-science tools giant offering immunoassay reagents, ELISA kits and lab instruments that compete with Gyrolab consumables and with PurePep-adjacent workflows in biopharma R&D and manufacturing.

TypeBroad incumbent
Description

Broad life-science tools and clinical diagnostics company with Bio-Plex multiplex immunoassays and protein analysis tools — overlapping customers in biopharma and academic research laboratories.

TypeOthers
Description

Sister company within Mesa Labs offering mass spectrometry-based genetic analysis (MassARRAY). Not a direct competitor but adjacent in Mesa's life sciences portfolio and relevant as a potential cross-sell / shared-buyer comparator.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gyros Protein Technologies

Bioanalytical Immunoassay & Peptide Synthesis Instrumentsgyrosproteintechnologies.com

Gyros Protein Technologies designs and manufactures automated nanoliter-scale immunoassay systems (Gyrolab) and peptide synthesizers (PurePep) for biopharmaceutical companies, CROs, and vaccine and cell/gene therapy developers, generating revenue through capital equipment, recurring consumables, and custom services.

What Gyros Protein Technologies does

Gyros Protein Technologies AB is a specialty life sciences instrument company headquartered in Uppsala, Sweden, with operations in the United States, that designs and manufactures automated nanoliter-scale immunoassay systems (Gyrolab xPlore and xPand) and a portfolio of automated peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, and Sonata/Sonata XT) under the Gyrolab and PurePep brands. The company's core technology is a proprietary microfluidic disc platform in which samples and reagents are delivered to 15-nanoliter streptavidin-bead columns by centrifugal force and capillary action, enabling immunoassay runs that complete in approximately one hour with up to 960 data points per day and dramatic reductions in sample and reagent consumption relative to plate-based ELISA. Column profile technology provides a distinctive data quality layer beyond conventional plate readers.

The company sells to large biopharmaceutical companies, contract research organizations (CROs), vaccine developers, and cell and gene therapy developers, addressing applications including pharmacokinetics, biomarker analysis, immunogenicity testing, impurity analysis, titer analysis, and therapeutic peptide synthesis. Revenue is generated through a capital equipment + recurring consumables + services model: one-time sales of Gyrolab systems and peptide synthesizers, ongoing pull-through from proprietary microfluidic discs, reagents and ready-to-use kits, and paid custom assay development plus IQ/OQ qualification services. Distribution combines direct enterprise field sales with a Certified CRO Partner Program that currently includes Charles River Laboratories, Bioagilytix, Resolian, QPS, Nuvisan, Agilex Biolabs, Frontage, Icon Laboratory Services, and Quality Assistance, alongside a Gyrolab User Zone customer portal providing training, protocols, and a method database. The company was founded in 1993 as Gyros AB, acquired Protein Technologies in 2016, and has operated as a division of Mesa Laboratories, Inc. (NASDAQ: MLAB) since 2019.

Gyros Protein Technologies firmographics

Firmographics
Name
Gyros Protein Technologies
Legal name
Gyros Protein Technologies AB
Website
https://gyrosproteintechnologies.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Short description
Gyros Protein Technologies designs and manufactures automated nanoliter-scale immunoassay systems (Gyrolab) and peptide synthesizers (PurePep) for biopharmaceutical companies, CROs, and vaccine and cell/gene therapy developers, generating revenue through capital equipment, recurring consumables, and custom services.
Ownership category
akta.pro rank

Gyros Protein Technologies industry classification

Industry
Product category
Bioanalytical Immunoassay & Peptide Synthesis Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
akta.pro secondary industries
Small-Molecule Analytical Development & Method Validation (CMC) (HLAGAHAF), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

Keywords

  • Immunoassay instruments
  • Peptide synthesis systems
  • Bioanalytical testing
  • Microfluidic lab technology
  • Pharmacokinetic assays

Where Gyros Protein Technologies is headquartered

Location

Headquarters

HQ city
Monmouth Junction
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Gyros Protein Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain

Revenue model

  1. Instrument/System Sales: Sale of Gyrolab immunoassay systems (xPlore, xPand) and peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, Sonata/Sonata XT). Capital equipment sales model with high transaction values.
  2. Consumables and Reagents: Recurring revenue from microfluidic discs, reagents, ready-to-use kits, and peptide synthesis consumables. Gyrolab microfluidic discs, reagents and ready-to-use kits deliver performance at nanoliter scale, reducing sample and reagent volumes.
  3. Custom Assay Services: Tailored assay development services supporting faster progress by helping optimize assay conditions, label biomolecules and prepare ready-to-use kit solutions. Includes IQ/OQ services and PEC services for peptide synthesis.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise instrument systems with custom pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Gyros Protein Technologies product offering

Product offering

Core offering

Gyros Protein Technologies manufactures and sells the Gyrolab automated nanoliter-scale immunoassay systems (xPlore and xPand) along with proprietary microfluidic discs, kits, reagents, and software for bioanalytical testing in drug development. Under its PurePep brand it sells peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, Sonata/Sonata XT) and purification kits. The company also offers custom assay development, IQ/OQ qualification services, and a Certified CRO Partner Program serving biopharma, CRO, vaccine, and cell/gene therapy customers globally.

Product overview

Gyros Protein Technologies offers two integrated product lines under the Gyrolab and PurePep brands: the Gyrolab automated nanoliter-scale immunoassay platform comprising Gyrolab xPlore and Gyrolab xPand systems with associated software, consumables, and kits for bioanalytical testing; and PurePep peptide synthesizers including Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, and Sonata/Sonata XT for solid-phase peptide synthesis. The company also provides related reagents, purification solutions like PurePep EasyClean, and services including custom assay development, IQ/OQ qualification, and a certified CRO partner network. The portfolio supports biotherapeutic drug development from discovery through manufacturing across applications including pharmacokinetics, biomarkers, immunogenicity, impurity analysis, and peptide therapeutics.

Differentiator

Problem solved

Functional benefit

Brands

  • Gyrolab: Automated nanoliter-scale immunoassay platform for bioanalytical testing, pharmacokinetics, biomarkers, immunogenicity, and cell & gene therapy applications.
  • PurePep

Products and services

  • Gyrolab xPlore Automated nanoliter-scale immunoassay system that uses microfluidic disc technology to deliver high-throughput pharmacokinetic, biomarker, and immunogenicity bioanalytical results for biopharmaceutical and CRO customers.
  • Gyrolab xPand Automated nanoliter-scale immunoassay instrument offering parallel processing for scalable bioanalytical workflows across drug development stages.
  • Gyrolab Microfluidic Discs Proprietary single-use discs containing nanoliter-scale streptavidin bead columns that enable automated immunoassay processing on Gyrolab xPlore and xPand systems.
  • Gyrolab 2G Generic PK Kit Ready-to-use kit for pharmacokinetic studies that provides improved assay flexibility, sensitivity, and sample efficiency for therapeutic antibody development on Gyrolab systems.
  • Gyrolab p24 Kit Assay kit designed for cell and gene therapy applications, enabling detection of lentiviral vector p24 components for immunogenicity monitoring.
  • Gyrolab Human Cytokine Kit Reagents Single-analyte cytokine assay reagents enabling automated detection of human cytokines (IL-4, IL-6, IL-10, IFN-gamma, TNF-alpha) on the Gyrolab platform.
  • Symphony/Quartet Peptide Synthesizer Legacy peptide synthesizer platform for solid-phase peptide synthesis supporting discovery and development peptide research.
  • Prelude X Peptide Synthesizer Advanced peptide synthesizer for automated solid-phase peptide synthesis with enhanced capabilities for complex sequences.
  • Sonata/Sonata XT Peptide Synthesizer Peptide synthesizer platform designed for scalable solid-phase peptide synthesis from research through manufacturing applications.
  • PS3 Peptide Synthesizer Legacy automated peptide synthesizer supporting standard and complex solid-phase peptide synthesis workflows.
  • Tribute UV-IR Peptide Synthesizer Peptide synthesizer featuring UV-IR monitoring for real-time synthesis tracking and optimization.
  • PurePep EasyClean Purification Kits Precipitation-free peptide purification kits that address HPLC delays, precipitation issues, and high costs in peptide purification workflows, saving 3-4 days per cycle.
  • Custom Assay Development Services Expert scientific services for assay optimization, custom biomolecule labeling, and preparation of ready-to-use kit solutions for Gyrolab-based workflows.
  • IQ/OQ Services for Peptide Synthesizers Installation and operational qualification services for peptide synthesizers ensuring compliance with regulatory requirements.

Quantifiable outcome

  • Process up to 960 data points per day with minimal supervision
  • +4 more outcomes

Companies that use Gyros Protein Technologies

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Gyros Protein Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Gyros Protein Technologies partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, major, strategic and notable.

  • Mesa LabscoreStrategic or Co-development Partner · 1 January 2019Since 2019, Gyros Protein Technologies is a division of Mesa Labs, a growing confederation of leading-edge brands dedicated to 'Protecting the Vulnerable'. Mesa Labs includes Gyros AB, Protein Technologies Inc., Gyros Protein Technologies AB, Agena Bioscience, GKE-GmbH, and other subsidiaries.
  • Charles River LaboratoriesmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner using the Gyrolab platform to support preclinical and clinical studies with consistent, high-quality immunoassay data. Automated workflows reduce resource use and increase throughput while providing stability needed for regulated environments.
  • BioagilytixmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner utilizing Gyrolab platform for biomarker and immunogenicity assays. Bioagilytix has utilized custom services including Custom Biomolecule Labelling Services for project-specific host-cell-protein assays.
  • ResolianmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner using Gyrolab systems for biomarker, pharmacokinetic and immunogenicity assay development, validation and execution for drug development.
  • QPSmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner leveraging Gyrolab platform capabilities for bioanalytical studies requiring high throughput and low sample volume.
  • NuvisanmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner using Gyrolab platform for agile bioanalytical support and client projects.
  • Agilex BiolabsmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner choosing Gyrolab for high throughput requirements and low reagent volume concerns, including discovery/preclinical mouse models and rare matrices.
  • FrontagemajorChannel Partner/ Reseller/ DistributorCertified CRO Partner utilizing Gyrolab for automated immunoassay workflows, high throughput sample analysis, and precious sample volume conservation.
  • Icon Laboratory ServicesmajorChannel Partner/ Reseller/ DistributorCertified CRO Partner using Gyrolab platform for robust studies requiring high throughput, low sample volume, or challenging analytes and matrices.
  • Quality AssistancemajorChannel Partner/ Reseller/ DistributorCertified CRO Partner utilizing Gyrolab for analytical methods including titer and residual process impurity analysis.
  • SymphogenstrategicStrategic or Co-development PartnerSymphogen A/S used Gyrolab system to develop 2-plex immunoassays for Sym015, a novel anti-cancer biotherapeutic comprising two monoclonal antibodies. Gyrolab methods are used for CMC, manufacturing control, and clinical bioanalysis.
  • Alexion PharmaceuticalsstrategicStrategic or Co-development PartnerAlexion used Gyrolab system for quantitation of free complement protein C5a in human plasma, developing assays to address C5 interference challenges. Gyrolab became their default technology of choice for free target quantification.
  • Oxford BiomedicastrategicStrategic or Co-development PartnerOxford Biomedica, pioneer in lentiviral vector gene therapy (Kymriah), adopted Gyrolab xPlore to measure lentiviral vector immunogenicity 24x faster with 10x less sample volume than ELISA.
  • SanofinotableTechnology or IntegrationSanofi Deutschland GmbH uses Gyrolab methods to support clinical and nonclinical studies, improving analyst efficiency in the lab and keeping teams at the cutting edge of drug development.

Scale indicators5 records

Recent moves3 records

Expansion highlights5 records

Gyros Protein Technologies competitors and assessment

Company assessment

Direct peers

  • Meso Scale Diagnostics: Direct competitor offering automated electrochemiluminescence immunoassay platforms (Meso QuickPlex, SECTOR) used in drug development, biomarkers and immunogenicity — same buyer set (biopharma, CROs) and similar workflow (PK, immunogenicity, biomarkers) as Gyrolab.
  • Luminex (DiaSorin): Multiplexed bead-based immunoassay platform (xMAP) used for biomarker, PK and immunogenicity assays across biopharma and CROs — directly overlapping with Gyrolab's biomarker and immunogenicity use cases.
  • Quanterix: Single-molecule array (Simoa) ultra-sensitive immunoassay platform targeting neurology, immunology and oncology biomarkers — comparable technology category (automated, low-volume immunoassays) and similar biopharma/biomarker buyer.
  • CEM Corporation: Peptide synthesizer vendor with the Liberty and Discover Bio series for SPPS — directly competes with PurePep Symphony, Prelude X and Sonata lines for therapeutic peptide development customers.
  • Biotage: Provides peptide synthesisers (Syro I/II) and purification/consumable solutions that overlap with PurePep EasyClean and SPPS workflows in pharmaceutical and academic peptide labs.

Broad incumbents

  • Bio-Techne (ProteinSimple): Larger life-science tools provider with automated immunoassay / protein analysis platforms (e.g., Simple Western/Jess) serving overlapping biopharma and academic customers; broader portfolio but competes directly for immunoassay workflow share.
  • Sartorius: Large bioprocess and lab products supplier whose bioanalytics portfolio (inc. cell line and process analytics) is sold into the same biopharma buyer set; competes indirectly for spend allocated to upstream/downstream characterization tools.
  • Thermo Fisher Scientific: Diversified life-science tools giant offering immunoassay reagents, ELISA kits and lab instruments that compete with Gyrolab consumables and with PurePep-adjacent workflows in biopharma R&D and manufacturing.
  • Bio-Rad Laboratories: Broad life-science tools and clinical diagnostics company with Bio-Plex multiplex immunoassays and protein analysis tools — overlapping customers in biopharma and academic research laboratories.

Others

  • Agena Bioscience: Sister company within Mesa Labs offering mass spectrometry-based genetic analysis (MassARRAY). Not a direct competitor but adjacent in Mesa's life sciences portfolio and relevant as a potential cross-sell / shared-buyer comparator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Gyros Protein Technologies social profiles

Digital presence

Gyros Protein Technologies compliance and trust

Trust signal

Compliance1 record

Gyros Protein Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gyros Protein Technologies leadership team

Management profile

Number of profiles

Gyros Protein Technologies funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gyros Protein Technologies M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gyros Protein Technologies

What does Gyros Protein Technologies do?

Gyros Protein Technologies manufactures and sells the Gyrolab automated nanoliter-scale immunoassay systems (xPlore and xPand) along with proprietary microfluidic discs, kits, reagents, and software for bioanalytical testing in drug development. Under its PurePep brand it sells peptide synthesizers (Symphony/Quartet, PS3, Tribute UV-IR, Prelude X, Sonata/Sonata XT) and purification kits. The company also offers custom assay development, IQ/OQ qualification services, and a Certified CRO Partner Program serving biopharma, CRO, vaccine, and cell/gene therapy customers globally.

Is Gyros Protein Technologies a public or private company?

Gyros Protein Technologies is a private company. It is classified as corporate owned and is currently operating.

When was Gyros Protein Technologies founded?

Gyros Protein Technologies was founded in 1993. It employs 51 to 100 people.

Where is Gyros Protein Technologies based?

Gyros Protein Technologies is headquartered in Monmouth Junction, United States, in the North America region.

How does Gyros Protein Technologies make money?

Three revenue lines are on record. Instrument/System Sales are the primary driver. The others are consumables and Reagents and custom Assay Services.

Who are Gyros Protein Technologies's main competitors?

Direct peers on record are Meso Scale Diagnostics, Luminex (DiaSorin), Quanterix, CEM Corporation and Biotage. Broad incumbents are Bio-Techne (ProteinSimple), Sartorius, Thermo Fisher Scientific and Bio-Rad Laboratories. Agena Bioscience is listed as an others.

Does Gyros Protein Technologies have an API?

No public API is recorded for Gyros Protein Technologies.

What industry is Gyros Protein Technologies in?

Gyros Protein Technologies's product category is Bioanalytical Immunoassay & Peptide Synthesis Instruments. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAHAF, Small-Molecule Analytical Development & Method Validation (CMC). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GyrosproteintechnologiesGetting Started with Automated Peptide Synthesis GuideGyros Protein Technologies published a technical guide on automated peptide synthesis, covering the evolution of the technology from manual methods pioneered in 1963 to modern automated systems with real-time monitoring and heating capabilities.PR NewswireVolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood TestVolitionRx Limited and Gyros Protein Technologies AB were jointly awarded over $1 million in Eurostars cash grants ($820,000 and $230,000 respectively) for a collaborative lung cancer blood test development project. The funding will support the development of 12 novel liquid biopsy assays combining Volition's Nu.Q™ immunoassay platform with Gyros Protein Technologies' Gyrolab® system, aimed at creating a validated triage panel for individuals testing positive in Low Dose CT lung cancer screening. The prospectively collected cohort study is intended to produce data ready for regulatory trials.GlobeNewswirePartnerTech grows along with GyrosPartnerTech signed a long-term cooperation agreement with Gyros AB, worth about SEK 150 million over 2½ years, to produce the Gyrolab Workstation microlaboratory. PartnerTech will deliver roughly SEK 30 million in products in 2007, and the deal covers the entire Gyrolab Workstation LIF analytical tool.GlobeNewswireGyros Appoints Chief Financial OfficerGyros AB appointed Bjorn Bontin as Chief Financial Officer and Investor Relations Manager, coming from IBS AB. Mathias Brandhammar was named Administration Director. The company, which miniaturizes laboratory applications, has over 90 employees and focuses on drug discovery and diagnostics.GlobeNewswireGyros Introduces new CD Microlaboratory for Gyrolab MALDI UsersGyros AB introduced the Gyrolab MALDI IMAC CD microlaboratory for detecting phosphorylated peptides via MALDI mass spectrometry. The device automates sample preparation, including enzymatic dephosphorylation, and processes up to 96 samples in parallel. It adds a second CD to the Gyrolab MALDI offering, expanding preparation options.GlobeNewswireGyros AB licenses patented technology to Fluidigm CorporationGyros AB and Fluidigm finalized a licensing agreement for Gyros' microfluidic patent covering elastomeric-layer devices. Fluidigm will use the technology for its Topaz Crystallizer and plans to expand product offerings. Gyros expects additional companies to join its licensing program.GlobeNewswireGyros AB Increases Successful Second Round FundingGyros AB announced that Schroder Ventures Life Sciences joined its second funding round, adding 6 MUSD to bring the total to approximately 36 MUSD. The company's first products, Gyrolab MALDI SP1 and Workstation, will be exhibited at conferences in the U.S. and Europe. The company plans to realize full potential in drug discovery and diagnostics.GlobeNewswireGyros AB Collaborating With Independent Cancer Research Organization to Evaluate New TechnologyGyros AB announced that its first application is under evaluation by the Ludwig Institute for Cancer Research, in collaboration with Professor Ulf Hellman. The microfluidic system automates sample preparation for MALDI mass spectrometry, aiming to improve sensitivity and throughput. Gyros expects a successful launch within months.GlobeNewswireGyros AB Headquarters Double in Size as Market Interest GrowsGyros AB completed purpose-built laboratories in Uppsala, doubling its headquarters size. The company plans to launch its first commercially available product in the proteomics area early in 2002. In-house manufacturing is the next step in commercialization.